Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/25/2022 | Vincerx Pharma, Inc. | LSAC | Purchase | Common Stock | 11.6k | $1.65 | $19.1k | | 08/24/2022 |
08/24/2022 | Vincerx Pharma, Inc. | LSAC | Purchase | Common Stock | 18.4k | $1.65 | $30.3k | | 08/24/2022 |
05/26/2022 | Vincerx Pharma, Inc. | LSAC | Grant | Stock Option (right to buy) | 15k | $1.61 | $24.2k | | 05/26/2022 |
03/03/2022 | Quince Therapeutics, Inc. | CRTX | Grant | Common Stock | 175k | $0.00 | $0 | | 03/03/2022 |
01/03/2022 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (right to buy) | 125k | $13.39 | $1.7M | | 01/03/2022 |
11/16/2021 | Quince Therapeutics, Inc. | CRTX | Exercise | Stock Option (right to buy) | 30k | $2.23 | $66.9k | | 11/16/2021 |
10/05/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 5k | $98.50 | $488.9k | | 10/05/2021 |
10/05/2021 | Quince Therapeutics, Inc. | CRTX | Exercise | Stock Option (Right to Buy) | 5k | $54.85 | $272.2k | | 10/05/2021 |
08/17/2021 | Quince Therapeutics, Inc. | CRTX | Exercise | Stock Option (right to buy) | 30k | $2.23 | $66.9k | | 08/16/2021 |
08/16/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 9.2k | $94.23 | $863k | | 08/16/2021 |
08/16/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 7.3k | $95.02 | $697k | | 08/16/2021 |
08/16/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 2.3k | $96.32 | $224.4k | | 08/16/2021 |
08/16/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 1.1k | $97.28 | $107k | | 08/16/2021 |
08/16/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 2.1k | $98.90 | $205.4k | | 08/16/2021 |
08/16/2021 | Quince Therapeutics, Inc. | CRTX | Exercise | Stock Option (right to buy) | 22k | $2.23 | $49.1k | | 08/16/2021 |
06/30/2021 | Vincerx Pharma, Inc. | LSAC | Purchase | Common Stock | 3.6k | $12.66 | $45.6k | | 06/29/2021 |
06/30/2021 | Quince Therapeutics, Inc. | CRTX | Exercise | Stock Option (right to buy) | 30k | $2.23 | $66.9k | | 06/28/2021 |
06/29/2021 | Vincerx Pharma, Inc. | LSAC | Purchase | Common Stock | 6.4k | $12.59 | $80.6k | | 06/29/2021 |
06/28/2021 | Quince Therapeutics, Inc. | CRTX | Exercise | Stock Option (right to buy) | 20k | $2.23 | $44.6k | | 06/28/2021 |
06/28/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 1k | $56.16 | $58.6k | | 06/28/2021 |
06/28/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 4.2k | $55.11 | $228.9k | | 06/28/2021 |
06/28/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 7.1k | $54.13 | $383.2k | | 06/28/2021 |
06/28/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 7.7k | $53.39 | $412.4k | | 06/28/2021 |
05/13/2021 | Vincerx Pharma, Inc. | LSAC | Grant | Stock Option (right to buy) | 20k | $16.34 | $326.8k | | 05/13/2021 |
02/09/2021 | Quince Therapeutics, Inc. | CRTX | Grant | Employee Stock Option (right to buy) | 40k | $46.10 | $1.8M | | 02/09/2021 |
12/23/2020 | Vincerx Pharma, Inc. | LSAC | Grant | Stock Option (right to buy) | 6.7k | $19.00 | $126.7k | | 12/23/2020 |
12/11/2020 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (Right to Buy) | 100k | $29.60 | $3M | | 12/11/2020 |
05/14/2020 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (Right to Buy) | 30k | $45.88 | $1.4M | | 05/14/2020 |
02/06/2020 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (Right to Buy) | 100k | $54.85 | $5.5M | | 02/06/2020 |
05/17/2013 | Anthera Pharmaceuticals Inc | ANTH | Grant | Stock option (right to buy) | 1.3M | $0.61 | $793k | | 05/17/2013 |
03/25/2013 | Anthera Pharmaceuticals Inc | ANTH | Grant | Common Stock | 67.6k | $0.00 | $0 | | 03/25/2013 |
01/03/2013 | Anthera Pharmaceuticals Inc | ANTH | Payment of Exercise | Common stock | 8.7k | $0.69 | $6k | | 01/03/2013 |
05/25/2012 | HANSEN MEDICAL INC | HNSN | Grant | Stock Option (Right to Buy) | 10k | $2.49 | $24.9k | | 05/25/2012 |
11/03/2011 | Anthera Pharmaceuticals Inc | ANTH | Sale | Common Stock | 15k | $6.88 | $103.2k | | 11/03/2011 |
10/25/2011 | Anthera Pharmaceuticals Inc | ANTH | Sale | Common Stock | 4.6k | $7.07 | $32.8k | By spouse | 10/25/2011 |
|